Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows provided by (used in) operating activities:
Net earnings	$ 567.2	$ 665.1
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization	809.8	732.7
Share-based compensation	66.1	79.9
Changes in operating assets and liabilities, net of acquired assets and liabilities
Income taxes	(174.7)	(181.2)
Receivables	(15.6)	(40.1)
Inventories	(86.2)	(38.0)
Accounts payable and accrued liabilities	(11.1)	(204.7)
Other assets and liabilities	24.1	(20.5)
Net cash provided by operating activities	1,179.7	993.1
Cash flows provided by (used in) investing activities:
Additions to instruments	(226.2)	(188.4)
Additions to other property, plant and equipment	(149.7)	(152.3)
Net investment hedge settlements	(5.3)	19.3
Business combination investments, net of acquired cash	(1,226.3)	(116.3)
Acquisition of intangible assets	(42.4)	(119.6)
Other investing activities	(3.8)	(39.7)
Net cash used in investing activities	(1,653.7)	(596.9)
Cash flows provided by (used in) financing activities:
Net payments on revolving facilities		(50.0)
Proceeds from senior notes	2,492.1	700.0
Redemption of senior notes	(863.0)
Dividends paid to stockholders	(142.8)	(148.0)
Proceeds from employee stock compensation plans	38.0	81.6
Business combination contingent consideration payments	(25.0)	(3.5)
Debt issuance costs	(22.7)	(7.9)
Deferred business combination payments		(8.8)
Repurchase of common stock	(237.0)	(795.8)
Other financing activities	(16.6)	(11.5)
Net cash provided by (used in) financing activities	1,223.0	(243.9)
Effect of exchange rates on cash and cash equivalents	18.2	1.0
Change in cash and cash equivalents	767.2	153.3
Cash and cash equivalents, beginning of year	525.5	415.8
Cash and cash equivalents, end of period	$ 1,292.7	$ 569.0